Systemic sclerosis & Raynaud's

Prognostic and functional importance of both overt and subclinical left ventricular systolic dysfunction in systemic sclerosis

Semin Arthritis RheumPublished Cohort study

Authors' conclusion

Both overt and subclinical SSc-associated LV dysfunction are associated with worse survival and impaired physical function.

Study context

Population
Australian Scleroderma Cohort Study participants meeting ACR/EULAR criteria for systemic sclerosis (SSc) with ≥1 echocardiographic LV ejection fraction (LVEF) measurement; secondary causes of LV dysfunction excludedLV-GLS at one centre, n = 218
Participants
1,141 participants
Exposure
Overt or subclinical LV dysfunction vs none
Outcome
Frequency and clinical implications of SSc-associated LV function impairment
Methodological detailsAustralian Scleroderma Cohort Study, generalised estimating equations (GEE) longitudinal modelling, Kaplan-Meier and Cox proportional hazard models
  • Australian Scleroderma Cohort Study
  • GEE longitudinal modelling
  • Kaplan-Meier and Cox proportional hazard models

Main finding

As reported in the abstract

Frequency of LV dysfunction

Ever recorded LVEF<50 %

2.4 %

Ever recorded LVEF≤40 %

0.6 %

Impaired LV-GLS despite LVEF≥50 % (n = 218)

21 %

Observational data: associations, not effects.

Further findings

Mortality, impaired LV-GLS (univariable)

HR for death (95 % CI)P value
Impaired LV-GLSUnivariable analyses3.4 (1.0–11.8)P = 0.05

WHO Class III/IV dyspnoea, LVEF<50 %

OR (95 % CI)P value
LVEF<50 %3.5 (1.6–7.7)P < 0.01

WHO Class III/IV dyspnoea, impaired LV-GLS

OR (95 % CI)P value
Impaired LV-GLS3.6 (1.4–9.2)P < 0.01

Impaired LV-GLS (LV-GLS>−16 %) despite LVEF≥50 %

Impaired LV-GLS despite LVEF≥50 %
21 %
  • LV-GLS data available for 90 % of participants at one centre (n = 218)

Physical function, LVEF<50 %

Shorter six-minute walk distance
P = 0.01
Higher HAQ-DI scores
P < 0.01
Lower Short Form-36 Physical Component Summary scores
P = 0.02

Original publication

Prognostic and functional importance of both overt and subclinical left ventricular systolic dysfunction in systemic sclerosis. Semin Arthritis Rheum. Published 6 April 2024. doi:10.1016/j.semarthrit.2024.152443

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.